Back to Search Start Over

Safety, Tolerability, and Clinical Assessment of Bemdaneprocel for Parkinson's Disease: 18-Month Results From a Phase 1 Study.

Authors :
Fasano, A.
Henchcliffe, C.
Sarva, H.
Lozano, A.
Kalia, S.
Yu, K.K.H.
Brennan, C.
Stemple, W.
Abid, N.
Yountz, M.
Enayetallah, A.
Lampron, A.
Tabar, V.
Source :
Parkinsonism & Related Disorders. May2024, Vol. 122, pN.PAG-N.PAG. 1p.
Publication Year :
2024

Subjects

Subjects :
*PARKINSON'S disease

Details

Language :
English
ISSN :
13538020
Volume :
122
Database :
Academic Search Index
Journal :
Parkinsonism & Related Disorders
Publication Type :
Academic Journal
Accession number :
177374606
Full Text :
https://doi.org/10.1016/j.parkreldis.2024.106129